Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study

In Canada, preventive therapy for latent tuberculosis infection (LTBI) has required multiple doses of medication over an extended period of time. Such regimens are associated with poor adherence and completion rates. A shortened treatment regimen of once weekly isoniazid plus rifapentine for 3 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyd, Amber, Heffernan, Courtney, Storey, Kate, Wild, T. Cameron, Long, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021900/
https://www.ncbi.nlm.nih.gov/pubmed/36962068
http://dx.doi.org/10.1371/journal.pgph.0000017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021900/
https://www.ncbi.nlm.nih.gov/pubmed/36962068
http://dx.doi.org/10.1371/journal.pgph.0000017

Ejemplares similares